Rivatane 2.5mg Tablet
Marketer
Medley Pharmaceuticals
Salt Composition
Rivaroxaban (2.5mg)
Overview Rivatane 2.5mg Tablet
Cardiothin 2.5mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers stroke and heart attack risk by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clot formation, it also mitigates clotting risks post-knee or hip replacement. It can be taken with or without food, consistently at the same time daily for optimal efficacy. Long-term, even lifelong, use may be necessary; never discontinue or alter dosage without physician consultation, as this significantly increases heart attack, stroke, or thrombosis risk. Lifestyle modifications, including cessation of smoking, a balanced diet, regular exercise, and weight management (if needed), further reduce clot risk. Increased bleeding (nosebleeds, bruising) is a common side effect; report any adverse reactions promptly. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concomitant use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't required.
Primary Ingredients of Rivatane 2.5mg Tablet
No information provided. Therefore, no text can be rewritten.
Uses of Rivatane 2.5mg Tablet
Managing and averting blood clot formation
Major Benefits of Rivatane 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rivatane 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Rivatane 2.5mg Tablet:
- Bleeding
How to use Rivatane 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rivatane 2.5mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Rivatane 2.5mg Tablet works:
Xarelto 2.5mg tablets are a new type of blood thinner, specifically a direct factor Xa inhibitor. Its mechanism of action involves blocking the activity of factor Xa, thereby reducing blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rivatane 2.5mg tablets with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Using Rivatane 2.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Using Rivatane 2.5mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rivatane 2.5mg Tablet, which can induce dizziness or fainting. These side effects could negatively impact your ability to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, Rivatane 2.5mg tablets require careful administration. Dosage modification may be necessary; physician consultation is advised. Rivatane 2.5mg tablets are contraindicated in patients exhibiting severe kidney disease.
LiverUNSAFE
The use of Rivatane 2.5mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Rivatane 2.5mg Tablet :
Should you forget to take your Rivatane 2.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rivatane 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-thiophene hybrid |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Factor Xa Inhibitors (Oral) |



